170 related articles for article (PubMed ID: 27406053)
1. Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein.
Manassero G; Guglielmotto M; Zamfir R; Borghi R; Colombo L; Salmona M; Perry G; Odetti P; Arancio O; Tamagno E; Tabaton M
Aging Cell; 2016 Oct; 15(5):914-23. PubMed ID: 27406053
[TBL] [Abstract][Full Text] [Related]
2. Tau deletion impairs intracellular β-amyloid-42 clearance and leads to more extracellular plaque deposition in gene transfer models.
Lonskaya I; Hebron M; Chen W; Schachter J; Moussa C
Mol Neurodegener; 2014 Nov; 9():46. PubMed ID: 25384392
[TBL] [Abstract][Full Text] [Related]
3. Endoplasmic reticulum stress mediates JNK-dependent IRS-1 serine phosphorylation and results in Tau hyperphosphorylation in amyloid β oligomer-treated PC12 cells and primary neurons.
Zhang X; Tang S; Zhang Q; Shao W; Han X; Wang Y; Du Y
Gene; 2016 Aug; 587(2):183-93. PubMed ID: 27185631
[TBL] [Abstract][Full Text] [Related]
4. Aβ monomer induces phosphorylation of Tau at Ser-214 through β2AR-PKA-JNK signaling pathway.
Wu H; Wei S; Huang Y; Chen L; Wang Y; Wu X; Zhang Z; Pei Y; Wang D
FASEB J; 2020 Apr; 34(4):5092-5105. PubMed ID: 32067279
[TBL] [Abstract][Full Text] [Related]
5. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
eNeuro; 2017; 4(2):. PubMed ID: 28374012
[TBL] [Abstract][Full Text] [Related]
6. Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β.
Vossel KA; Xu JC; Fomenko V; Miyamoto T; Suberbielle E; Knox JA; Ho K; Kim DH; Yu GQ; Mucke L
J Cell Biol; 2015 May; 209(3):419-33. PubMed ID: 25963821
[TBL] [Abstract][Full Text] [Related]
7. Tau pathogenesis is promoted by Aβ1-42 but not Aβ1-40.
Hu X; Li X; Zhao M; Gottesdiener A; Luo W; Paul S
Mol Neurodegener; 2014 Nov; 9():52. PubMed ID: 25417177
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of amyloid β-FcγRIIb neurotoxicity and tau pathologies by targeting LYN.
Gwon Y; Kim SH; Kim HT; Kam TI; Park J; Lim B; Cha H; Chang HJ; Hong YR; Jung YK
FASEB J; 2019 Mar; 33(3):4300-4313. PubMed ID: 30540497
[TBL] [Abstract][Full Text] [Related]
9. The Unexpected Role of Aβ1-42 Monomers in the Pathogenesis of Alzheimer's Disease.
Tamagno E; Guglielmotto M; Monteleone D; Manassero G; Vasciaveo V; Tabaton M
J Alzheimers Dis; 2018; 62(3):1241-1245. PubMed ID: 29103036
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory.
Fá M; Puzzo D; Piacentini R; Staniszewski A; Zhang H; Baltrons MA; Li Puma DD; Chatterjee I; Li J; Saeed F; Berman HL; Ripoli C; Gulisano W; Gonzalez J; Tian H; Costa JA; Lopez P; Davidowitz E; Yu WH; Haroutunian V; Brown LM; Palmeri A; Sigurdsson EM; Duff KE; Teich AF; Honig LS; Sierks M; Moe JG; D'Adamio L; Grassi C; Kanaan NM; Fraser PE; Arancio O
Sci Rep; 2016 Jan; 6():19393. PubMed ID: 26786552
[TBL] [Abstract][Full Text] [Related]
11. Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation.
Shin WS; Di J; Cao Q; Li B; Seidler PM; Murray KA; Bitan G; Jiang L
Alzheimers Res Ther; 2019 Oct; 11(1):86. PubMed ID: 31627745
[TBL] [Abstract][Full Text] [Related]
12. Direct interaction of soluble human recombinant tau protein with Abeta 1-42 results in tau aggregation and hyperphosphorylation by tau protein kinase II.
Rank KB; Pauley AM; Bhattacharya K; Wang Z; Evans DB; Fleck TJ; Johnston JA; Sharma SK
FEBS Lett; 2002 Mar; 514(2-3):263-8. PubMed ID: 11943163
[TBL] [Abstract][Full Text] [Related]
13. Nonphosphorylated tau slows down Aβ
Beeg M; Battocchio E; De Luigi A; Colombo L; Natale C; Cagnotto A; Corbelli A; Fiordaliso F; Diomede L; Salmona M; Gobbi M
J Biol Chem; 2021; 296():100664. PubMed ID: 33865852
[TBL] [Abstract][Full Text] [Related]
14. FcγRIIb-SHIP2 axis links Aβ to tau pathology by disrupting phosphoinositide metabolism in Alzheimer's disease model.
Kam TI; Park H; Gwon Y; Song S; Kim SH; Moon SW; Jo DG; Jung YK
Elife; 2016 Nov; 5():. PubMed ID: 27834631
[TBL] [Abstract][Full Text] [Related]
15. Estrogens Inhibit Amyloid-β-Mediated Paired Helical Filament-Like Conformation of Tau Through Antioxidant Activity and miRNA 218 Regulation in hTau Mice.
Guglielmotto M; Manassero G; Vasciaveo V; Venezia M; Tabaton M; Tamagno E
J Alzheimers Dis; 2020; 77(3):1339-1351. PubMed ID: 32804095
[TBL] [Abstract][Full Text] [Related]
16. Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis.
Lee M; McGeer E; McGeer PL
Neurobiol Aging; 2015 Jan; 36(1):42-52. PubMed ID: 25169677
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro.
Ma QL; Lim GP; Harris-White ME; Yang F; Ambegaokar SS; Ubeda OJ; Glabe CG; Teter B; Frautschy SA; Cole GM
J Neurosci Res; 2006 Feb; 83(3):374-84. PubMed ID: 16385556
[TBL] [Abstract][Full Text] [Related]
18. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
Chu J; Lauretti E; Craige CP; Praticò D
J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099
[TBL] [Abstract][Full Text] [Related]
20. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
